Menu
Back to User profile » Dr Tomoaki Hoshino
Papers published by Dr Tomoaki Hoshino:
The Efficacy and Safety of First-Line Single-Inhaler Triple versus Dual Therapy in Controller-Naïve and Symptomatic Adults with Asthma: A Preliminary Retrospective Cohort Study
Fujiki R, Kawayama T, Furukawa K, Kinoshita T, Matsunaga K, Hoshino T
Journal of Asthma and Allergy 2023, 16:227-237
Published Date: 28 February 2023
Daytime and Nighttime Visual Analog Scales May Be Useful in Assessing Asthma Control Levels Before and After Treatment
Fujiki R, Kawayama T, Furukawa K, Kinoshita T, Matsunaga K, Hoshino T
Journal of Asthma and Allergy 2022, 15:1549-1559
Published Date: 26 October 2022
Poor Asthma Control in Schoolchildren May Lead to Lower Lung Function Trajectory from Childhood to Early Adulthood: A Japanese Cohort Study
Tsuneyoshi S, Kawayama T, Sasaki J, Kinoshita T, Yano C, Tokunaga Y, Matsuoka M, Imaoka H, Matsunaga K, Furukawa K, Hoshino T
Journal of Asthma and Allergy 2022, 15:885-896
Published Date: 30 June 2022
Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer
Ichiki M, Wataya H, Yamada K, Tsuruta N, Takeoka H, Okayama Y, Sasaki J, Hoshino T
OncoTargets and Therapy 2017, 10:5107-5113
Published Date: 24 October 2017
Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls
Kawayama T, Kinoshita T, Matsunaga K, Kobayashi A, Hayamizu T, Johnson M, Hoshino T
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:295-303
Published Date: 10 February 2016
“Frequent exacerbator” is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease
Tomioka R , Kawayama T, Suetomo M, Kinoshita T, Tokunaga Y, Imaoka H, Matsunaga K, Okamoto M, Hoshino T
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:207-216
Published Date: 3 February 2016